Edity Therapeutics
Biotechnology ResearchView the employees at
Edity Therapeutics-
Ofer Levy VP R&D, Edity Therapeutics Ltd.
-
Rising Star
Reut Nave Senior Scientist at Edity Therapeutics-
Mevaseret Zion, Jerusalem District, Israel
-
Top 10%
Dor Shimon Scientist at Edity-
Rising Star
Megi Cemel David Research Scientist at EdiTy Therapeutics-
Israel
-
Top 10%
Michal Golan Mashiach, Ph.D Founder & CEO EdiTy Therapeutics, Applied Genomics - NGS, Bioinformatics, Gene-Editing-
Top 5%
Overview
Edity is developing a novel delivery platform that uses immune cells to transfer therapeutic proteins to the target cells of patients. Our technology allows for precise modulation of intracellular pathways of disease using a range of proteins including gene editors, immune sensors, enzymes and intrabodies.
-